Wellington Management Group
ACET icon

Wellington Management Group’s Adicet Bio ACET Stock Holding History

Wellington Management Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48,519
Closed -$1.89M – 1799
2023
Q2 		$1.89M Buy
48,519
+17,155
+55% +$1.51M ﹤0.01% 1488
2023
Q1 		$2.89M Sell
31,364
-18,858
-38% -$2.37M ﹤0.01% 1414
2022
Q4 		$7.18M Buy
+50,222
New +$12.5M ﹤0.01% 1175

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Wellington Management Group's ACET Position: Q3 2023 in Review

Wellington Management Group sold out of Adicet Bio (ACET) in Q3 2023, closing a stake of 48,519 shares — an estimated $1.89M sold.

Wellington Management Group first reported a position in ACET in Q4 2022 and held it in 3 quarters. The position peaked at $7.18M in Q4 2022. 83 funds tracked by Wall St. Rank hold ACET as of Q3 2023.

  • Wellington Management Group reported no remaining Adicet Bio position as of Q3 2023 after selling out during the quarter.
  • Wellington Management Group sold 48,519 Adicet Bio shares in Q3 2023, an estimated $1.89M.
  • Wellington Management Group first reported a position in Adicet Bio in Q4 2022 and held it in 3 quarters.
  • Wellington Management Group's Adicet Bio position peaked at $7.18M in Q4 2022.
  • 83 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2023.

Based on Wellington Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.